Multiinstitutional validation of the University of California at San Francisco low-grade glioma prognostic scoring system: Clinical article

Journal of Neurosurgery

Volumn 111, Issue 2, 2009, Pages 203-210

  Chang, Edward F ^a   Clark, Aaron ^a   Jensen, Randy L ^b   Bernstein, Mark ^c   Guha, Abhijit ^c   Carrabba, Giorgio ^c   Mukhopadhyay, Debabrata ^c   Kim, Won ^d   Liau, Linda M ^d   Chang, Susan M ^a   Smith, Justin S ^a   Berger, Mitchel S ^a   McDermott, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Low grade glioma; Prognosis; Scoring system; Survival; Validation

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; CANCER GRADING; GLIOMA; HUMAN; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LOG RANK TEST; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POPULATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; STRATIFICATION; SURVIVAL; TREATMENT PLANNING; TUMOR VOLUME; UNITED STATES; VALIDATION STUDY;

AGE FACTORS; DISEASE PROGRESSION; GLIOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; PROGNOSIS; RESEARCH DESIGN; SURVIVAL RATE;

EID: 68849094078     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.2.JNS081101     Document Type: Article

References (27)

1. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, et al: Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923-929, 1999 (Pubitemid 29525456)
2. Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR, et al: Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 48:825-830, 2000 (Pubitemid 30742657)
3. Berger MS, Deliganis AV, Dobbins J, Keles GE: The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784-1791, 1994 (Pubitemid 24301834)
4. Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, et al: Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715-1721, 2003 (Pubitemid 38029041)
5. Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, et al: Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol 21:251-255, 2003 (Pubitemid 46606153)
6. Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, et al: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24:2707-2714, 2006 (Pubitemid 46630566)
7. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al: Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227-235, 2008
8. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al: Preoperative prognostic classification for hemispheric low-grade gliomas in adults. J Neurosurg 109:817-824, 2008
9. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381-1393, 1997
10. Hamlat A, Saikali S, Chaperon J, Carsin-Nicol B, Calve ML, Lesimple T, et al: Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas. J Neurooncol 79:159-168, 2006 (Pubitemid 44349944)
11. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, et al: Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133-3138, 2004 (Pubitemid 41103727)
12. Janny P, Cure H, Mohr M, Heldt N, Kwiatkowski F, Lemaire JJ, et al: Low grade supratentorial astrocytomas. Management and prognostic factors. Cancer 73:1937-1945, 1994
13. Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, de Witte O, et al: Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316-324, 2002 (Pubitemid 34170840)
14. Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al: A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549-556, 1996 (Pubitemid 26404297)
15. Keles GE, Lamborn KR, Berger MS: Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735-745, 2001
16. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225, 2002 (Pubitemid 34212595)
17. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, et al: Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129-3140, 1997 (Pubitemid 27377505)
18. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, et al: Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872-878, 1996 (Pubitemid 26125547)
19. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076-2084, 2002 (Pubitemid 34408798)
20. Rudoler S, Corn BW, Werner-Wasik M, Flanders A, Preston PE, Tupchong L, et al: Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/magnetic resonance imaging era. Am J Clin Oncol 21:23-27, 1998 (Pubitemid 28092966)
21. Schuurman PR, Troost D, Verbeeten B Jr, Bosch DA: 5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases. Acta Neurochir (Wien) 139:2-7, 1997
22. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, et al: Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267-2276, 2002 (Pubitemid 34441653)
23. Shaw EG, Scheithauer BW, Gilbertson DT, Nichols DA, Laws ER, Earle JD, et al: Postoperative radiotherapy of supratentorial low-grade gliomas. Int J Radiat Oncol Biol Phys 16:663-668, 1989
24. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al: Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338-1345, 2008
25. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-990, 2005 (Pubitemid 41323034)
26. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C: Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581-587, 1998
27. Whitton AC, Bloom HJ: Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. Int J Radiat Oncol Biol Phys 18:783-786, 1990